Enhancing recommendation diversity and accuracy with product paths and time decay mechanisms. [PDF]
Wang X, Ming W, Fu Z, Ma X.
europepmc +1 more source
Intravenous versus subcutaneous immunoglobulin in patients with haematological malignancies: time-driven activity-based costing. [PDF]
de Albornoz SC +16 more
europepmc +1 more source
Seeing Through Packaging: Eye-Tracking Evidence on How Product Visual Strategy and Unit Size Shape Visual Attention and Consumer Evaluation. [PDF]
Guo Z +5 more
europepmc +1 more source
Potential lipid-lowering effects of <i>Coffea arabica</i> pulp extract product in hyperlipidemia-obese subjects: a randomized double-blind placebo-controlled trial. [PDF]
Buranapin S +8 more
europepmc +1 more source
Signals of Diagnostic Product Ions of Kavalactones in Their ESI Mass Spectra-Implications for Isomer Differentiation and Identification of Kavalactone Conjugates. [PDF]
Kasperkowiak M +4 more
europepmc +1 more source
Extracting Mechanistic Information from an Open Data Set for a Pharma-Relevant Suzuki-Miyaura Cross-Coupling Reaction. [PDF]
Franklin BA +9 more
europepmc +1 more source
China's petrochemical plants' CO<sub>2</sub> emissions and high-impact contributors for carbon-neutrality production. [PDF]
Chen X +5 more
europepmc +1 more source
Retrospective analysis of U.S. Food and Drug Administration recalls of artificial tear solutions from 2014 to 2025. [PDF]
Bhattacharya A, Kang PC.
europepmc +1 more source
An Electrospray Sequential Mass Spectrometry Fragmentation Scheme of Erythromycin A and Its Application for the Elucidation of the Structures of Its Natural Co-Metabolites. [PDF]
Jiang C, Gates PJ.
europepmc +1 more source
Effectiveness and safety of an ayurvedic nutraceutical for improving clinical parameters of liver function in participants with metabolic dysfunction-associated steatotic liver disease: a randomized, placebo-controlled, preliminary phase 2 exploratory clinical trial. [PDF]
Messier H +4 more
europepmc +1 more source

